Tweet
October 18 2022
Ana T. Duggan, Jonathan Audet, Vanessa Laminman, Geoffrey A. Peters, Alwyn C. Go, Mable Chan, Kristina Dimitrova, Emily Haidl, Darian Hole, Brynn Kaplen, Christine Bonner, Erika Landry, Natalie Knox, David Safronetz, Jim Strong, Andrea Tyler, Chanchal Yadav, and Morag Graham
National Microbiology Laboratory, Winnipeg, Manitoba, Canada
Introduction
Following the first suspected clinical identification of a Monkeypox case in Canada in May 2022, biological specimens from presumptive cases were submitted to the National Microbiology Laboratory (NML) in Winnipeg, Manitoba, for diagnostic confirmation and shotgun metagenomic sequencing. Cases were most often associated with ulcerated lesions and were frequently identified at sexual health clinics or as part of outreach to the gay, bisexual, and other men who have sex with men (GBMSM) communities. As with most affected countries during the 2022 human Monkeypox virus (hMPXV) outbreak, there was no previous history of hMPXV in Canada and no established methods for genomic surveillance.
Ana T. Duggan, Jonathan Audet, Vanessa Laminman, Geoffrey A. Peters, Alwyn C. Go, Mable Chan, Kristina Dimitrova, Emily Haidl, Darian Hole, Brynn Kaplen, Christine Bonner, Erika Landry, Natalie Knox, David Safronetz, Jim Strong, Andrea Tyler, Chanchal Yadav, and Morag Graham
National Microbiology Laboratory, Winnipeg, Manitoba, Canada
Introduction
Following the first suspected clinical identification of a Monkeypox case in Canada in May 2022, biological specimens from presumptive cases were submitted to the National Microbiology Laboratory (NML) in Winnipeg, Manitoba, for diagnostic confirmation and shotgun metagenomic sequencing. Cases were most often associated with ulcerated lesions and were frequently identified at sexual health clinics or as part of outreach to the gay, bisexual, and other men who have sex with men (GBMSM) communities. As with most affected countries during the 2022 human Monkeypox virus (hMPXV) outbreak, there was no previous history of hMPXV in Canada and no established methods for genomic surveillance.